For the Quarter Ending March 2026
Sertraline Hydrochloride Prices in North America
- In United States, the Sertraline Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, reflecting higher input costs.
- The Sertraline Hydrochloride Production Cost Trend increased significantly in March 2026 as producer prices rose 4.0% year-over-year.
- Consumer prices grew 3.3% year-over-year in March 2026, elevating logistics costs for the Sertraline Hydrochloride Price Index.
- Industrial production grew 0.7% year-over-year in March 2026, reflecting utility constraints that impacted Sertraline Hydrochloride synthesis costs.
- Retail sales increased 4.0% year-over-year in March 2026, supporting a robust Sertraline Hydrochloride Demand Outlook at pharmacies.
- An unemployment rate of 4.3% in March 2026 maintained insurance coverage, securing steady Sertraline Hydrochloride prescription fulfillment.
- Consumer confidence reached an index of 91.8 in March 2026, correlating with strengthened generic antidepressant prescriptions during Q1 2026.
- The Manufacturing Index expanded in March 2026, ensuring steady reagent availability for the Sertraline Hydrochloride Price Forecast.
Why did the price of Sertraline Hydrochloride change in March 2026 in North America?
- Toluene feedstock costs climbed sharply in March 2026, directly elevating active pharmaceutical ingredient synthesis expenses.
- United States pharmaceutical inventories contracted in January 2026, tightening available supply for downstream drug formulation.
- Brent crude oil futures peaked in March 2026, driving up upstream petrochemical precursor production costs.
Sertraline Hydrochloride Prices in APAC
- In China, the Sertraline Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, driven by escalating feedstock costs.
- The Sertraline Hydrochloride production cost trend increased as the Producer Price Index rose 0.5% in March 2026.
- The Sertraline Hydrochloride demand outlook strengthened alongside a 1.0% Consumer Price Index increase in March 2026.
- Industrial production grew 5.7% in March 2026, supporting stabilized API manufacturing operating rates for Sertraline Hydrochloride.
- Retail sales grew 1.7% in March 2026, reflecting softer consumer spending that slightly constrained broader pharmaceutical budgets.
- Urban unemployment reached 5.4% in March 2026, correlating with strengthened depression diagnosis rates and higher API consumption.
- Low consumer confidence at 91.6 in February 2026 drove increased clinical need for generic Sertraline Hydrochloride.
- The Manufacturing Index expanded in March 2026, supporting a stable Sertraline Hydrochloride Price Forecast amid recovered industrial activity.
- Chinese exports of generic APIs to India remained robust while precautionary buying reduced merchant supplies in Q1 2026.
Why did the price of Sertraline Hydrochloride change in March 2026 in APAC?
- Upstream benzene feedstock costs spiked in early March 2026 amid escalating global geopolitical conflicts.
- Buyers secured forward cargoes, tightening available spot inventories for intermediate producers during March 2026.
- Defensive run cuts at domestic cracker operations tightened upstream benzene supply during March 2026.
Sertraline Hydrochloride Prices in Europe
- In Germany, the Sertraline Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, driven by surging energy costs.
- The Sertraline Hydrochloride Production Cost Trend increased in March 2026 as inflation reached 2.7 percent year-over-year.
- Producer prices fell 0.2 percent in March 2026, reflecting slightly eased upstream basic chemical production costs.
- The Manufacturing Index expanded in March 2026, indicating robust industrial activity across the pharmaceutical supply chain.
- Industrial production remained stagnant at 0.0 percent in February 2026, maintaining flat baseline chemical precursor availability.
- Retail sales grew 0.7 percent and unemployment stayed at 4.2 percent in February 2026, supporting prescriptions.
- The Sertraline Hydrochloride Demand Outlook strengthened in March 2026 as consumer confidence hit negative 24.7, driving prescriptions.
- The Sertraline Hydrochloride Price Forecast trended upward in February 2026 as United States pharmaceutical import demand strengthened.
Why did the price of Sertraline Hydrochloride change in March 2026 in Europe?
- European natural gas and energy costs surged in March 2026 due to Middle East geopolitical conflicts.
- Costs for toluene, a key precursor, strengthened in March 2026 alongside firming regional gasoline markets.
- United States import demand for pharmaceutical preparations strengthened in February 2026, driving German export volumes.
For the Quarter Ending December 2025
Sertraline Hydrochloride Prices in North America
- In the United States, the Sertraline Hydrochloride Price Index rose quarter-over-quarter in Q4 2025, driven by rising production costs.
- Sertraline Hydrochloride production costs increased, with the Producer Price Index rising 3.0% year-over-year in November 2025.
- Demand was indirectly supported by a 3.3% year-over-year increase in retail sales in November 2025.
- The 4.4% unemployment rate in December 2025 supported demand but increased labor expenses for manufacturers.
- Methyl Amine feedstock prices edged higher in late December 2025 due to tighter spot availability.
- US tariffs on Active Pharmaceutical Ingredients from China and India caused inflationary pressure on drug production.
- US industrial production rose 2.0% year-over-year in December 2025, yet manufacturing production worsened in October 2025.
- The Consumer Price Index increased 2.7% year-over-year in December 2025, contributing to higher operational costs.
Why did the price of Sertraline Hydrochloride change in December 2025 in North America?
- Methyl Amine feedstock prices edged higher in late December 2025 due to tighter spot availability.
- US tariffs on Active Pharmaceutical Ingredients from China and India caused inflationary effects on drug production.
- Producer Price Index rose 3.0% year-over-year in November 2025, indicating rising input costs.
Sertraline Hydrochloride Prices in APAC
- In China, the Sertraline Hydrochloride Price Index fell quarter-over-quarter in Q4 2025, influenced by declining production costs.
- Sertraline Hydrochloride production costs declined in Q4 2025, as the Producer Price Index fell by 1.9% in December 2025.
- Aromatic feedstock costs, like benzene, weakened in Q4 2025 due to supply overhang, easing chemical production expenses.
- Sertraline Hydrochloride demand outlook faced headwinds from weak consumer spending, with retail sales growing 0.9% in December 2025.
- Weak inflationary pressure (CPI 0.8%) and 5.1% unemployment in December 2025 reflected broader economic moderation.
- The Manufacturing Index expanded in December 2025, supporting industrial activity and chemical supply chains.
- Industrial production increased by 5.2% in December 2025, indicating robust manufacturing growth for chemical inputs.
- China's API market demonstrated robust growth in 2025, driven by an aging population and chronic diseases.
Why did the price of Sertraline Hydrochloride change in December 2025 in APAC?
- Producer Price Index declined by 1.9% in December 2025, reducing Sertraline Hydrochloride input costs.
- Aromatic feedstock costs weakened in Q4 2025, easing overall chemical production expenses.
- Weak consumer demand, with retail sales up 0.9% in December 2025, indirectly impacted demand.
Sertraline Hydrochloride Prices in Europe
- In Germany, the Sertraline Hydrochloride Price Index rose quarter-over-quarter in Q4 2025, driven by strengthening feedstock methanol costs.
- The Sertraline Hydrochloride Price Forecast trended upward as pharmaceutical production volumes expanded significantly throughout 2025.
- Sertraline Hydrochloride Production Cost Trend escalated when electricity and natural gas prices rose in October 2025.
- Sertraline Hydrochloride Demand Outlook remained robust as retail sales grew 1.5% year-over-year in December 2025.
- High unemployment of 6.2% in December 2025 supported sustained volume demand for antidepressant medications like Sertraline Hydrochloride.
- Feedstock methanol prices strengthened in Q4 2025, outweighing the 2.5% decline in broader producer prices in December 2025.
- Pharmaceutical sector output expanded in Q4 2025, contrasting with the contracting manufacturing index observed in December 2025.
- Industrial production rose 0.8% in November 2025, ensuring stable solvent availability for Sertraline Hydrochloride synthesis.
- Headline inflation of 1.8% in December 2025 supported stable pricing structures for finished Sertraline Hydrochloride formulations.
Why did the price of Sertraline Hydrochloride change in December 2025 in Europe?
- Feedstock methanol prices strengthened in Q4 2025, increasing essential input costs for manufacturers.
- Pharmaceutical production volumes expanded in 2025, driving strong demand for active pharmaceutical ingredients.
- Electricity and natural gas prices rose in October 2025, elevating energy-intensive production overheads.
For the Quarter Ending September 2025
North America
- In United States, Sertraline Hydrochloride Price Index rose in Q3 2025, driven by robust pharmaceutical demand and rising input costs.
- Sertraline Hydrochloride production costs increased in Q3 2025, influenced by a 3.0% CPI rise in September and higher energy prices.
- Demand for psychotropic medications remained robust in Q3 2025, supported by strong overall pharmaceutical product demand.
- Demand outlook is positive, bolstered by a 5.42% retail sales increase and 4.3% unemployment rate in September 2025.
- Rising producer-level costs, indicated by a 2.6% PPI increase in August 2025, impacted Sertraline Hydrochloride manufacturing expenses.
- US natural gas prices experienced an uptick during Q3 2025, contributing to increased energy feedstock costs for chemical production.
- Weakening consumer confidence, declining to 94.2 in September 2025, signals bearish future out-of-pocket healthcare spending.
- US pharmaceutical exports declined in July 2025, while imports edged up, influencing domestic supply dynamics and chemical overcapacity.
Why did the price of Sertraline Hydrochloride change in September 2025 in North America?
- Rising production costs, evidenced by a 2.6% PPI increase in August 2025, pressured Sertraline Hydrochloride prices upward.
- Robust demand for psychotropic medications in Q3 2025 provided upward price support despite broader chemical oversupply.
- Increased energy costs for chemical manufacturers in Q3 2025 contributed to higher overall manufacturing expenses.
APAC
- In China, the Sertraline Hydrochloride Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices and manufacturing contraction.
- Sertraline Hydrochloride production costs faced downward pressure in Q3 2025, as producer prices decreased by 2.3% in September 2025.
- Petrochemical feedstock costs, including benzene, remained stable in Q3 2025, contributing to steady input expenses.
- Demand for Sertraline Hydrochloride was supported by China's government action plan for health consumption in 2025.
- China's pharmaceutical industry saw growth in 2025, driven by an aging population and rising healthcare demands.
- Retail sales increased by 3.0% in September 2025, indirectly supporting healthcare spending and consumer access.
- Industrial production grew by 6.5% in September 2025, indicating a stable supply chain for pharmaceutical manufacturing.
- Global chemical overcapacity, particularly from China, tightened margins in Q3 2025, suggesting continued price pressure.
Why did the price of Sertraline Hydrochloride change in September 2025 in APAC?
- Producer Price Index decreased by 2.3% in September 2025, reducing Sertraline Hydrochloride manufacturing input costs.
- Consumer Price Index decreased by 0.3% in September 2025, indicating deflationary pressures on overall market pricing.
- Global chemical overcapacity, especially from China, contributed to tightened margins for Sertraline Hydrochloride in Q3 2025.
Europe
- In Germany, the Sertraline Hydrochloride Price Index rose quarter-over-quarter, influenced by strengthening aromatic hydrocarbon markets in 2025.
- Sertraline Hydrochloride production costs faced upward pressure from high European energy costs during Q3 2025.
- Demand for Sertraline Hydrochloride was supported by Germany's growing pharmaceutical market and chronic disease prevalence in Q3 2025.
- European chemical output declined in 2025, tightening Sertraline Hydrochloride supply and its precursors.
- Germany's industrial production decreased 1.0% year-over-year in September 2025, impacting upstream chemical supply.
- Producer prices decreased 1.7% year-over-year in September 2025, mainly due to lower energy prices.
- The Manufacturing Index for Q3 2025 was contracting, indicating a broader German manufacturing sector slowdown.
- Consumer Price Index increased 2.4% year-over-year in September 2025, suggesting rising operational expenses.
- Stable unemployment at 6.3% in September 2025 supported consistent healthcare spending and pharmaceutical demand.
Why did the price of Sertraline Hydrochloride change in September 2025 in Europe?
- Strengthening aromatic hydrocarbon markets and high energy costs pressured Sertraline Hydrochloride production expenses.
- Declining European chemical output and reduced EU27 capacity utilization tightened Sertraline Hydrochloride supply.
- Increased pharmaceutical demand, driven by an aging population, supported the Sertraline Hydrochloride price trend.
